Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants

Schizophrenia Research

Volumn 153, Issue 1-3, 2014, Pages 25-31

  Allott, Kelly A ^a   Schäfer, Miriam R ^a,b   Thompson, Andrew ^a,c   Nelson, Barnaby ^a   Bendall, Sarah ^a   Bartholomeusz, Cali F ^d   Yuen, Hok Pan ^a   McGorry, Patrick D ^a   Schlögelhofer, Monika ^b   Bechdolf, Andreas ^a,e   Amminger, G Paul ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c SUSSEX PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Affect recognition; Conversion; Early psychosis; Fear; Neutral emotion; Trait marker

Indexed keywords

ACCURACY; ADOLESCENT; ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; EMOTION; EMOTION RECOGNITION; FEAR; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LONGITUDINAL STUDY; MALE; NEUTRAL EMOTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PSYCHOSIS; RISK ASSESSMENT; AGE; CHILD; COMPLICATION; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOTIC DISORDERS; RECOGNITION; REGRESSION ANALYSIS; RISK; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; CHILD; EMOTIONS; FEAR; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RECOGNITION (PSYCHOLOGY); REGRESSION ANALYSIS; RISK; YOUNG ADULT;

EID: 84895833157     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.01.037     Document Type: Article

References (50)

1. Addington J., Penn D., Woods S.W., Addington D., Perkins D.O. Facial affect recognition in individuals at clinical high risk for psychosis. Br. J. Psychiatry 2008, 192(1):67-68.
2. Addington J., Piskulic D., Perkins D., Woods S.W., Liu L., Penn D.L. Affect recognition in people at clinical high risk of psychosis. Schizophr. Res. 2012, 140(1-3):87-92.
3. Amminger G.P., Schafer M.R., Papageorgiou K., Klier C.M., Cotton S.M., Harrigan S.M., Mackinnon A., McGorry P.D., Berger G.E. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch. Gen. Psychiatry 2010, 67(2):146-154.
4. Amminger G.P., Schäfer M.R., Klier C.M., Schlögelhofer M., Mossaheb N., Thompson A., Bechdolf A., Allott K., McGorry P.D., Nelson B. Facial and vocal affect perception in people at ultra-high risk of psychosis, first-episode schizophrenia and healthy controls. Early Interv. Psychiatry 2012, 6(4):450-454.
5. Amminger G.P., Schafer M.R., Klier C.M., Slavik J.M., Holzer I., Holub M., Goldstone S., Whitford T.J., McGorry P.D., Berk M. Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals. Mol. Psychiatry 2012, 17(12):1150-1152.
6. Amminger G.P., Schafer M.R., Papageorgiou K., Klier C.M., Schlogelhofer M., Mossaheb N., Werneck-Rohrer S., Nelson B., McGorry P.D. Emotion recognition in individuals at clinical high-risk for schizophrenia. Schizophr. Bull. 2012, 38(5):1030-1039.
7. Andreasen N.C., Endicott J., Spitzer R.L., Winokur G. Family history method using diagnostic criteria - reliability and validity. Arch. Gen. Psychiatry 1977, 34(10):1229-1235.
8. Bediou B., Asri F., Brunelin J., Krolak-Salmon P., D'Amato T., Saoud M., Tazi I. Emotion recognition and genetic vulnerability to schizophrenia. Br. J. Psychiatry 2007, 191:126-130.
9. Brewer W.J., Wood S.J., Phillips L.J., Francey S.M., Pantelis C., Yung A.R., Cornblatt B., McGorry P.D. Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr. Bull. 2006, 32(3):538-555.
10. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., Seidman L.J., Perkins D., Tsuang M., McGlashan T., Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch. Gen. Psychiatry 2008, 65(1):28-37.
11. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Earlbaum Associates, Hillsdale, NJ. 2nd ed.
12. Cornblatt B.A., Carrion R.E., Addington J., Seidman L., Walker E.F., Cannon T.D., Cadenhead K.S., McGlashan T.H., Perkins D.O., Tsuang M.T., Woods S.W., Heinssen R., Lencz T. Risk factors for psychosis: impaired social and role functioning. Schizophr. Bull. 2012, 38(6):1247-1257.
13. Couture S.M., Penn D.L., Roberts D.L. The functional significance of social cognition in schizophrenia: a review. Schizophr. Bull. 2006, 32(S1):S44-S63.
14. Davis P.J., Gibson M.G. Recognition of posed and genuine facial expressions of emotion in paranoid and nonparanoid schizophrenia. J. Abnorm. Psychol. 2000, 109(3):445-450.
15. Demenescu L.R., Kortekaas R., den Boer J.A., Aleman A. Impaired attribution of emotion to facial expressions in anxiety and major depression. PLoS One 2010, 5(12):e15058.
16. Derntl B., Seidel E.M., Kryspin-Exner I., Hasmann A., Dobmeier M. Facial emotion recognition in patients with bipolar I and bipolar II disorder. Br. J. Clin. Psychol. 2009, 48:363-375.
17. Eack S.M., Mermon D.E., Montrose D.M., Miewald J., Gur R.E., Gur R.C., Sweeney J.A., Keshavan M.S. Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr. Bull. 2010, 36(6):1081-1088.
18. Edwards J., Pattison P.E., Jackson H.J., Wales R.J. Facial affect and affective prosody recognition in first-episode schizophrenia. Schizophr. Res. 2001, 48:235-253.
19. Edwards J., Jackson H.J., Pattison P.E. Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review. Clin. Psychol. Rev. 2002, 22:789-832.
20. Feinberg T.E., Rifkin A., Schaffer C., Walker E. Facial discrimination and emotional recognition in schizophrenia and affective disorders. Arch. Gen. Psychiatry 1986, 43(3):276-279.
21. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Patient Edition (SCID-I/P, 2/2001 Revision) Biometrics Research Department 2001, New York State Psychiatric Institute, New York.
22. Garety P.A., Bebbington P., Fowler D., Freeman D., Kuipers E. Implications for neurobiological research of cognitive models of psychosis: a theoretical paper. Psychol. Med. 2007, 37(10):1377-1391.
23. Green M.J., Phillips M.L. Social threat perception and the evolution of paranoia. Neurosci. Biobehav. Rev. 2004, 28(3):333-342.
24. Green M.F., Bearden C.E., Cannon T.D., Fiske A.P., Hellemann G.S., Horan W.P., Kee K., Kern R.S., Lee J., Sergi M.J., Subotnik K.L., Sugar C.A., Ventura J., Yee C.M., Nuechterlein K.H. Social cognition in schizophrenia, part 1: performance across phase of illness. Schizophr. Bull. 2012, 38(4):854-864.
25. Hall J., Whalley H.C., McKirdy J.W., Romaniuk L., McGonigle D., McIntosh A.M., Baig B.J., Gountouna V.-E., Job D.E., Donaldson D.I., Sprengelmeyer R., Young A.W., Johnstone E.C., Lawrie S.M. Overactivation of fear systems to neutral faces in schizophrenia. Biol. Psychiatry 2008, 64(1):70-73.
26. Holt D.J., Kunkel L., Weiss A.P., Goff D.C., Wright C.I., Shin L.M., Rauch S.L., Hootnick J., Heckers S. Increased medial temporal lobe activation during the passive viewing of emotional and neutral facial expressions in schizophrenia. Schizophr. Res. 2006, 82(2-3):153-162.
27. Howes O.D., Montgomery A.J., Asselin M.C., Murray R.M., Valli I., Tabraham P., Bramon-Bosch E., Valmaggia L., Johns L., Broome M., McGuire P.K., Grasby P.M. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch. Gen. Psychiatry 2009, 66(1):13-20.
28. Howes O.D., Bose S.K., Turkheimer F., Valli I., Egerton A., Valmaggia L.R., Murray R.M., McGuire P. Dopamine synthesis capacity before onset of psychosis: a prospective (18)F-DOPA PET imaging study. Am. J. Psychiatry 2011, 168(12):1311-1317.
29. Irani F., Seligman S., Kamath V., Kohler C., Gur R.C. A meta-analysis of emotion perception and functional outcomes in schizophrenia. Schizophr. Res. 2012, 137(1-3):203-211.
30. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am. J. Psychiatry 2003, 160(1):13-23.
31. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
32. Kee K.S., Horan W.P., Mintz J., Green M.F. Do the siblings of schizophrenia patients demonstrate affect perception deficits?. Schizophr. Res. 2004, 67(1):87-94.
33. Kline J.S., Smith J.E., Ellis H.C. Paranoid and nonparanoid schizophrenic processing of facially displayed affect. J. Psychiatr. Res. 1992, 26(3):169-182.
34. Kohler C.G., Turner T.H., Bilker W.B., Brensinger C.M., Siegel S.J., Kanes S.J., Gur R.E., Gur R.C. Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am. J. Psychiatry 2003, 160(10):1768-1774.
35. Kohler C.G., Walker J.B., Martin E.A., Healey K.M., Moberg P.J. Facial emotion perception in schizophrenia: a meta-analytic review. Schizophr. Bull. 2010, 36(5):1009-1019.
36. Kohler C.G., Hoffman L.J., Eastman L.B., Healey K., Moberg P.J. Facial emotion perception in depression and bipolar disorder: a quantitative review. Psychiatry Res. 2011, 188(3):303-309.
37. Kucharska-Pietura K., David A.S., Masiak M., Phillips M.L. Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness. Br. J. Psychiatry 2005, 187:523-528.
38. Marenco S., Weinberger D.R. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev. Psychopathol. 2000, 12(3):501-527.
39. McGorry P.D., Hickie I.B., Yung A.R., Pantelis C., Jackson H.J. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust. N. Z. J. Psychiatry 2006, 40:616-622.
40. Montgomery S.A., Asberg M. New depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134(APR):382-389.
41. Morrison A.P., French P., Walford L., Lewis S.W., Kilcommons A., Green J., Parker S., Bentall R.P. Cognitive therapy for the prevention of psychosis in people at ultra-high risk - randomised controlled trial. Br. J. Psychiatry 2004, 185:291-297.
42. Oswald W.D., Roth E. Number Combination Test (Zahlen-Verbindungs-Test; ZVT) 1987, Testzentrale, Gottingen, Germany.
43. Pinkham A.E., Penn D.L., Perkins D.O., Graham K.A., Siege M. Emotion perception and social skill over the course of psychosis: a comparison of individuals "at-risk" for psychosis and individuals with early and chronic schizophrenia spectrum illness. Cogn. Neuropsychiatry 2007, 12:198-212.
44. Seiferth N.Y., Pauly K., Habel U., Kellermann T., Shah N.J., Ruhrmann S., Klosterkotter J., Schneider F., Kircher T. Increased neural response related to neutral faces in individuals at risk for psychosis. NeuroImage 2008, 40(1):289-297.
45. Surguladze S., Russell T., Kucharska-Pietura K., Travis M.J., Giampietro V., David A.S., Phillips M.L. A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia. Biol. Psychiatry 2006, 60(5):423-431.
46. Thompson A.D., Bartholomeusz C., Yung A.R. Social cognition deficits and the 'ultra high risk' for psychosis population: a review of literature. Early Interv. Psychiatry 2011, 5(3):192-202.
47. van Rijn S., Aleman A., de Sonneville L., Sprong M., Ziermans T., Schothorst P., van Engeland H., Swaab H. Misattribution of facial expressions of emotion in adolescents at increased risk of psychosis: the role of inhibitory control. Psychol. Med. 2011, 41(3):499-508.
48. Van't Wout M., Aleman A., Kessels R.P.C., Laroi F., Kahn R.S. Emotional processing in a non-clinical psychosis-prone sample. Schizophr. Res. 2004, 68(2-3):271-281.
49. Yung A.R., Phillips L.J., McGorry P.D., McFarlane C.A., Francey S., Harrigan S., Patton G.C., Jackson H.J. Prediction of psychosis - a step towards indicated prevention of schizophrenia. Br. J. Psychiatry 1998, 172:14-20.
50. Yung A.R., Yuen H.-P., Berger G.E., Francey S., Hung T., Phillips L.J., McGorry P.D. Declining transition rate in Ultra High Risk (prodromal) services: dilution or reduction of risk?. Schizophr. Bull. 2007, 33:673-681.